--In Testing Conducted by a U.S. Research Institute, Ceeker Correctly Detected Anthrax 100% of the Time--
--Provides First Responders with a Simple and Reliable Tool to Help Quickly Distinguish Public Health Emergencies from Mere Nuisances--
--Study Data to be Presented by Prof. Lou Reinisch at Biodetection Technologies 2009--
BALTIMORE and CHRISTCHURCH, New Zealand, June 25 /PRNewswire/ -- Veritide Ltd., a developer of innovative biological identification and detection solutions, today reported that new independent data to be presented at the Biodetection Technologies 2009 conference confirm the exceptional accuracy of its Ceeker(TM) (pronounced "seeker") portable bacterial detection device in discriminating between anthrax spores and similar-looking hoax substances. The data show that in over two weeks of testing at the Midwest Research Institute in Florida, the company's Ceeker scanner accurately identified 100% of the anthrax samples used and was correct in 95% of tests involving hoax substances. These test results are consistent with similar results produced last year by a New Zealand forensic testing agency, Environmental Science and Research (ESR).
"We knew that our innovative Ceeker is capable of producing outstanding results in distinguishing between anthrax and look-alike hoax substances, and now we have definitive data confirming its performance," said Andrew Rudge, Ph.D., Chief Executive Officer of Veritide. "Even better, these extraordinary results were generated by a small portable handheld system that requires no special skills or training to operate and that can produce a result within minutes, enabling first responders to rapidly determine whether the situation is a nuisance or a major threat to public health."
The Ceeker employs optical detection technology developed at New Zealand's University of Canterbury. It uses ultraviolet light and special algorithms to detect bacterial spores and provides test results within minutes, without the need for wet chemistry or analytic processes that can be difficult to handle in the field. The Ceeker is capable of producing test results from very small amounts of sample and does not consume or destroy the sample being tested, allowing it to be re-analyzed later for forensic applications.
In contrast, existing detection approaches require longer and more complex processing to distinguish anthrax from other substances (between 30 minutes and three days), their accuracy is inferior to the Ceeker and the sample is typically destroyed during testing.
The new data will be presented on June 26, 2009 at Biodetection Technologies 2009 by Professor Lou Reinisch, an inventor of the Ceeker technology and Professor of Physics and Department Head at
John Delaney is Captain, Arlington County, Virginia Fire Department and Manager, National Medical Response Team-National Capital Region, home to the Pentagon and many other major U.S. government and corporate facilities. Capt. Delaney commented, "With responsibility for helping to ensure the safety of the hundreds of thousands of people who live and work in the Capital Region, my department welcomes the availability of technologically advanced solutions that enhance our ability to carry out our mission. The Veritide Ceeker is an excellent example--it is extremely versatile, easy-to-use and fast--results are ready in minutes. Most importantly, the new test data being presented this week confirm that the Ceeker is very reliable, enabling front-line decision makers to rapidly and confidently validate initial threat assessments that can ultimately have a far-reaching impact on public safety and well-being. The National Capital Region generally receives on average one alert a day or more regarding the potential presence of anthrax, so this device can only enhance our first responder capabilities and accuracy."
The Ceeker has also been previously validated by forensic laboratory ESR, which conducted multiple rounds of testing using anthrax simulants and hoax substances. The successful U.S. test results have triggered significant sales from U.S. customers who had pre-ordered the Ceeker but were waiting for positive direct anthrax testing results before proceeding.
Dr. Rudge added, "Achieving these results represents a significant milestone and positions Veritide as the first company to offer proven technology capable of accurately and reliably detecting lethal anthrax spores, and to do so without destroying the sample. These new testing results are expected to unlock large potential markets for Veritide in North America and around the globe. We currently are in the process of identifying potential partners and additional investors to ensure this important technology is available worldwide."
To learn more about the Veritide Ceeker, go to www.veritide.com.
The 14th International Biodetection Technologies conference is being held June 25-26, 2009 at the Marriot Baltimore Inner Harbor in Baltimore, MD. Dr. Reinisch's presentation is scheduled at 11:00 am EDT on June 26, 2009. For more information visit www.knowledgefoundation.com.
New Zealand-based Veritide Ltd. is committed to developing innovative biological identification and detection solutions. Our novel technologies are based on research conducted at the University of Canterbury in Christchurch, New Zealand and we partner with end-users to ensure the rapid development and commercialization of reliable, high performance products. Veritide's first product, the Ceeker(TM), is an innovative handheld portable system for first responders that independent testing confirms is capable of detecting anthrax spores rapidly, simply and with great accuracy. The Ceeker is currently being launched in North America and around the world. Veritide is backed by venture capital firms Endeavour i-cap and Ngai Tahu Capital. For more information, visit www.veritide.com
Contacts: Veritide Ltd: U.S. Media: Andrew Rudge Barbara Lindheim Chief Executive Officer GendeLLindheim BioCom Partners +64 3 372 3506 +1 212 918-4650 email@example.com
|SOURCE Veritide Ltd.|
Copyright©2009 PR Newswire.
All rights reserved